SIP and NEC are abdominal emergencies in premature and critically ill neonates. For suspected disease: stop feeds, decompress the stomach, obtain urgent imaging and labs, start broad-spectrum antibiotics when NEC is suspected beyond mild observation-only disease, involve pediatric surgery early, and stabilize perfusion, ventilation, glucose, electrolytes, coagulation, platelets, pain, and temperature.
| Step | Action | Why It Matters |
|---|---|---|
| 1. Recognize | Any preterm infant with acute abdominal distension, discoloration, bloody stool, bilious emesis/residuals, apnea/bradycardia, metabolic acidosis, thrombocytopenia, hypotension, or sudden deterioration should be evaluated for NEC or SIP. | NEC and SIP can progress rapidly; early symptoms overlap with sepsis, ileus, obstruction, volvulus, milk-protein enterocolitis, and candidiasis. |
| 2. Stop enteral intake | Hold feeds and oral medications. Place an orogastric or Replogle tube to low intermittent suction or gravity according to severity and local practice. | Reduces bowel distension, aspiration risk, and ongoing enteral stress during intestinal inflammation/perforation. |
| 3. Stabilize ABCs | Assess airway, breathing, circulation, perfusion, blood pressure, temperature, glucose, urine output, lactate, and acid-base status. Escalate respiratory support if worsening acidosis, apnea, shock, or abdominal distension compromises ventilation. | Systemic illness and bowel ischemia worsen each other; shock and hypoxia accelerate intestinal injury. |
| 4. Image urgently | Obtain abdominal radiographs: supine AP plus left lateral decubitus or cross-table lateral if perforation is suspected. Repeat serial films based on severity, often every 6–12 hours early. | Radiographs identify pneumatosis, portal venous gas, fixed loops, gasless abdomen, and pneumoperitoneum. |
| 5. Start evaluation | CBC/differential, platelets, CRP if used locally, blood culture, electrolytes, glucose, BUN/creatinine, blood gas, lactate, coagulation profile if severe, type/screen if unstable or surgical. | Guides severity, transfusion, renal dosing, electrolyte correction, and operative readiness. |
| 6. Treat | Start broad-spectrum antibiotics for definite or strongly suspected NEC. Support with fluids, blood products, inotropes, analgesia, PN, and surgical consultation. | NEC is inflammatory, infectious, ischemic, and systemic; treatment must be multidisciplinary. |
| Condition | Practical Definition | Typical Population |
|---|---|---|
| NEC | Acute inflammatory intestinal disease with mucosal injury, bacterial invasion/dysbiosis, hemorrhagic necrosis, and possible perforation. Radiographic pneumatosis intestinalis and/or portal venous gas supports definite NEC. | Most cases occur in premature infants. Risk increases as gestational age and birth weight decrease; term NEC is more often associated with congenital heart disease, hypoperfusion, polycythemia, intestinal anomaly, or severe illness. |
| SIP | Usually focal, isolated intestinal perforation, often terminal ileum, without diffuse bowel necrosis or classic pneumatosis. Presentation may be sudden abdominal distension, bluish abdominal discoloration, pneumoperitoneum, or gasless abdomen. | Very preterm/VLBW or ELBW infants, often during the first 1–2 weeks. Associated factors include extreme prematurity, chorioamnionitis, early postnatal steroids, and exposure to indomethacin, especially with hydrocortisone. |
| Medical NEC | NEC managed without surgery: bowel rest, decompression, antibiotics, hemodynamic and respiratory support, serial exams, and serial imaging. | Bell stage II or selected stage III without perforation and with clinical improvement. |
| Surgical NEC / SIP | Disease requiring drain or laparotomy because of perforation, clinical deterioration despite medical care, obstruction/mass/stricture, or severe non-resolving abdominal disease. | ELBW infants may be candidates for bedside primary peritoneal drainage; stable/larger infants may proceed to laparotomy based on surgical assessment. |
Prematurity is the strongest risk factor for NEC. Additional risks include IUGR, abnormal antenatal Doppler flow, perinatal hypoxia/asphyxia, low systemic blood flow, ductal-dependent or low-output CHD, significant PDA, prolonged empiric antibiotics, prolonged NPO, lack of antenatal steroids, infection, formula exposure, exchange transfusion, and intestinal anomalies.
| Feature | Suggests SIP | Suggests NEC |
|---|---|---|
| Timing | Often earlier in ELBW infants, commonly first week but may occur up to 2 weeks. | Often later in the most immature infants; age of onset is inversely related to gestational age. |
| Pathology pattern | Focal isolated perforation, usually terminal ileum, with relatively normal surrounding bowel. | Segmental or multifocal inflammation/necrosis; may progress to perforation, strictures, short bowel, and systemic shock. |
| Radiology | Pneumoperitoneum or gasless abdomen; classically no pneumatosis intestinalis or portal venous gas. | Pneumatosis intestinalis, portal venous gas, fixed dilated loop, bowel wall thickening, paucity of gas, or pneumoperitoneum if perforated. |
| Systemic signs | May have sudden distension and instability; systemic inflammatory signs may be less prominent early. | Frequently systemic: apnea/bradycardia, temperature instability, acidosis, thrombocytopenia, hypotension, poor perfusion, DIC, oliguria. |
| Management overlap | NPO, decompression, antibiotics, stabilization, urgent surgery consult. Drain may be used in unstable ELBW infants. | NPO, decompression, antibiotics, stabilization, urgent surgery consult; surgery for perforation or failure of medical therapy. |
| Domain | Recommended Practice | Avoid / Caution |
|---|---|---|
| Human milk | Prioritize mother’s own milk. Use donor human milk when mother’s milk is unavailable and local policy supports it. Support mothers to continue pumping during NEC recovery. | Avoid unnecessary interruption of milk expression support. Formula decisions should be individualized when human milk is unavailable. |
| Feeding practice | Use standardized feeding protocols, cautious advancement in high-risk infants, careful assessment of feeding cues and intolerance, and early trophic feeds when clinically appropriate. | Avoid prolonged unnecessary NPO because intestinal disuse may impair mucosal adaptation and motility. |
| Perfusion & oxygenation | Maintain normoxia, normothermia, adequate systemic blood flow, blood pressure, hemoglobin, and acid-base status. | Avoid hypoxia, shock, excessive vasoconstriction, and unrecognized low-output states. |
| Antibiotic stewardship | Use empiric antibiotics appropriately and stop when cultures and clinical course do not support infection. | Avoid prolonged empiric antibiotic exposure without indication. |
| Medication safety | Review exposure to NSAIDs, steroids, acid blockade, and other medications that may affect intestinal risk in ELBW infants. | Use concurrent indomethacin and early hydrocortisone only when benefits clearly outweigh intestinal risk. |
| Probiotics | Follow institutional policy, product quality controls, and national guidance. Do not use as treatment for active NEC. | Routine universal probiotic use is not supported by AAP guidance in settings lacking pharmaceutical-grade regulated products, especially in infants <1000 g. |
| Category | Findings That Increase Concern | Immediate Implication |
|---|---|---|
| Systemic signs | Apnea, bradycardia, respiratory distress, temperature instability, lethargy, irritability, poor perfusion, hypotension, oliguria, metabolic acidosis, elevated lactate, bleeding tendency. | Assess for sepsis and shock; obtain cultures/labs; escalate monitoring and cardiorespiratory support. |
| Abdominal signs | Distension, tenderness, discoloration, shiny/erythematous abdominal wall, ileus, absent bowel sounds, bilious emesis, bloody stool, abdominal mass, increased gastric output. | Stop feeds, decompress, urgent imaging, surgery notification if severe or progressive. |
| Bell stage I — suspected | Mild systemic or GI signs with non-diagnostic radiographs. | Observation, labs, imaging trend, NPO/antibiotics based on clinical risk and local pathway. |
| Bell stage II — definite | Clinical illness plus pneumatosis intestinalis and/or portal venous gas, with or without systemic toxicity. | Medical NEC bundle: NPO, decompression, antibiotics, serial imaging/exam/labs, PN, surgery awareness. |
| Bell stage III — advanced | Shock, DIC, severe acidosis, worsening ventilation, fixed loop, abdominal wall inflammation, pneumoperitoneum, or impending perforation. | Full resuscitation, urgent surgery, blood products, broad antibiotics, consider antifungal coverage in selected high-risk nonresponders. |
Occult blood or guaiac-positive stool alone is not a reliable NEC screen in tube-fed premature infants, and feeding residuals alone do not reliably predict intestinal injury. Interpret all findings in the full clinical context.
| Area | Recommended Evaluation | Clinical Notes |
|---|---|---|
| Laboratory | CBC with differential and platelets; blood gas; lactate; electrolytes; glucose; BUN/creatinine; CRP trend if used; blood culture; coagulation profile and type/screen if severe or surgical. | Thrombocytopenia, neutropenia, hyponatremia, hyperkalemia, acidosis, high lactate, and coagulopathy suggest severe disease or shock. |
| Radiography | Supine AP abdomen; add left lateral decubitus/cross-table lateral if perforation is suspected. Repeat every 6–12 hours early if evolving disease. | Diagnostic signs include pneumatosis, portal venous gas, persistent/fixed loop, and pneumoperitoneum. |
| Ultrasound | Use when radiographs are equivocal but concern remains high, or to evaluate perfusion, bowel wall thickness, pneumatosis, portal venous gas, complex ascites, or free air. | Portable ultrasound can help when bowel gas is sparse or when transport is unsafe; it should not delay surgery for obvious perforation. |
| Differential diagnosis | Sepsis with ileus, spontaneous intestinal perforation, volvulus/malrotation, obstruction, milk-protein enterocolitis, infectious enterocolitis, systemic candidiasis, metabolic disease. | Volvulus is a surgical emergency; persistent bilious vomiting or sudden shock with abdominal signs requires urgent surgical/radiology discussion. |
| Component | Bedside Action | Escalation Trigger |
|---|---|---|
| Bowel rest & decompression | NPO. Stop oral medications. Place OG/Replogle to low intermittent suction; monitor color and volume of output. | Persistent bilious/bloody output, distension, or poor decompression. |
| Antibiotics | For definite NEC or strong suspicion: ampicillin + aminoglycoside + anaerobic coverage is common; piperacillin-tazobactam may be an alternate depending on local antibiogram/formulary. | Septic shock, positive cultures, renal dysfunction, fungal risk, or failure to improve warrants consultant/pharmacy/ID input. |
| Respiratory | Support oxygenation and ventilation. Consider intubation if severe distension, acidosis, apnea, shock, or CPAP worsens bowel distension. | Rising lactate, worsening acidosis, apnea/bradycardia, increasing oxygen/pressure needs. |
| Circulation | Restore perfusion with careful isotonic fluid boluses for shock, vasoactive support as needed, and close urine-output/lactate monitoring. | Hypotension, poor pulses, oliguria, base deficit, lactate rise, persistent metabolic acidosis. |
| Blood products | Correct anemia, thrombocytopenia, and coagulopathy according to severity and local transfusion thresholds. | Bleeding, DIC, platelets falling rapidly, impending surgery, or shock. |
| Nutrition | Start PN early if prolonged bowel rest is expected. Provide adequate amino acids/energy and monitor glucose, electrolytes, triglycerides, and cholestasis markers. | Anticipated NPO >3–5 days, Bell II/III, surgery, ostomy, or intestinal failure risk. |
| Pain & comfort | Provide analgesia, minimal handling, thermoregulation, family updates, and developmentally supportive care. | Severe abdominal tenderness, ventilated infant, drain/laparotomy, or escalating instability. |
| Diagnosis | Suggested regimen (Baylor Ed. 33, Table 6-1) | Alternative | Maximum duration |
|---|---|---|---|
| Medical NEC without pneumatosis | Ampicillin + amikacin | Piperacillin–tazobactam — only in selected cases where routine cover is judged inadequate on local susceptibility patterns, or the infant fails to improve on the standard regimen | 7 days |
| Medical NEC with pneumatosis | Ampicillin + amikacin + metronidazole | 7 days | |
| Surgical NEC, spontaneous intestinal perforation, post-drain or post-laparotomy | Ampicillin + amikacin + metronidazole | 10 days |
| Scenario | Typical Approach | Notes |
|---|---|---|
| Suspected NEC, rapid improvement, non-diagnostic imaging | Short course or discontinuation after reassessment may be appropriate if cultures negative and clinical/radiographic concern resolves. | Avoid overtreatment, but do not under-treat evolving disease. |
| Medical NEC with pneumatosis, no perforation | Commonly 7 days in some pathways, or 7–10 days depending on severity and clinical response. | Baylor pathway supports shorter maximum durations for selected medical NEC; Belize/older pathways often use 7–10 days. |
| Surgical NEC, SIP, drain, or laparotomy | Often approximately 10 days, individualized by operative findings, source control, cultures, and clinical course. | Longer therapy may be needed for persistent sepsis, abscess, bacteremia, fungal infection, or incomplete source control. |
| Antifungal coverage | Not routine for all NEC. Consider in high-risk infants with central line/TPN, thrombocytopenia, Candida colonization, poor response, or unit epidemiology. | Discuss with ID/pharmacy and follow local fungal-risk policy. |
Free air on abdominal imaging requires immediate pediatric surgery notification and preparation for drain or laparotomy. Do not wait for further deterioration.
| Trigger | Interpretation | Action |
|---|---|---|
| Pneumoperitoneum | Perforated bowel until proven otherwise. | Immediate pediatric surgery notification. Prepare for drain or laparotomy. |
| Clinical deterioration despite medical care | Progressive bowel necrosis, perforation, uncontrolled sepsis, or worsening shock. | Escalate support; repeat imaging; urgent surgical decision. |
| Fixed dilated loop, abdominal mass, worsening distension | Possible necrotic segment, obstruction, evolving perforation, or stricture. | Serial imaging and early surgery involvement. |
| Rapid platelet fall, DIC, rising lactate/acidosis | Severe systemic disease or worsening ischemia. | Treat shock/coagulopathy; consider operative source control if abdomen worsening. |
| ELBW unstable infant | May not tolerate laparotomy/anesthesia initially. | Primary peritoneal drainage can temporize and sometimes definitively manage selected SIP/NEC. |
| Larger/stable infant with surgical abdomen | May tolerate definitive exploration. | Laparotomy aims to control sepsis, remove nonviable bowel, preserve bowel length, and manage stoma/anastomosis decisions. |
| Phase | Practical Care | Monitoring |
|---|---|---|
| Readiness to refeed | Consider when abdominal exam normalizes, gastric output decreases and becomes non-bilious, stool/ostomy output returns, inflammatory/sepsis markers improve, and imaging stabilizes. | Do not refeed solely by day number; integrate surgical and dietitian input. |
| Initial feeds | Use mother’s own milk when available. Donor human milk is preferred for preterm infants when mother’s milk is unavailable. Elemental or semi-elemental formula may be considered when human milk is unavailable or malabsorption/allergy is a concern. | Start trophic feeds; monitor emesis, distension, output, acidosis, stool, weight, and cardiorespiratory tolerance. |
| Advancement | Advance slowly based on disease severity, residual bowel length, ostomy output, and prior intolerance. High-risk intestinal failure may need 5–10 mL/kg/day increments 1–2 times weekly; moderate-risk patients may tolerate faster advancement. | Track growth, urine sodium if poor growth/intestinal losses, electrolytes, conjugated bilirubin, liver enzymes, triglycerides, and micronutrients if prolonged PN. |
| Central line & PN | Keep central access while PN is needed and until adequate enteral intake/growth are demonstrated. Remove when risk of line infection exceeds benefit and enteral regimen is stable. | Consider intestinal rehabilitation consult for surgical NEC, SIP with prolonged PN, short bowel, ostomy, cholestasis, multiple failed feeding attempts, or poor growth. |
| Complications | Watch for stricture, recurrent NEC, fistula, short bowel, high-output ostomy, PN-associated cholestasis, metabolic bone disease, micronutrient deficiency, oral aversion, and neurodevelopmental impairment. | Arrange surgical/GI/nutrition/neurodevelopmental follow-up and clear family discharge teaching. |
| Time Window | Minimum Monitoring | Documentation |
|---|---|---|
| First 0–6 hours after suspicion | Continuous cardiorespiratory and SpO₂ monitoring; frequent BP; strict intake/output; serial abdominal exams; initial labs/culture/gas/lactate; imaging; surgery notification if Bell II/III or SIP/perforation concern. | Time of symptom onset, NPO time, decompression tube, antibiotic start time, imaging interpretation, surgery discussion, parent update. |
| First 24–48 hours | Serial abdominal exams, girth only if unit uses it consistently, repeat gases/lactate/electrolytes/CBC/platelets/coags as severe disease requires, repeat radiographs 6–12 hourly if evolving. | Trend table: abdomen, ventilation, perfusion, urine output, platelets, lactate, radiology, antibiotic plan. |
| Days 3–10 | Daily reassessment of antibiotic need, PN adequacy, cholestasis risk, central-line necessity, pain, sedation, renal function, and feeding-readiness signs. | Daily multidisciplinary plan with neonatology, surgery, nursing, pharmacy, nutrition, and family. |
| Post-recovery / discharge | Growth, stool/ostomy output, electrolytes, micronutrients if prolonged PN, oral feeding skills, neurodevelopment, surgical complications, stoma care if applicable. | Written feeding plan, red flags, follow-up appointments, line/stoma teaching, emergency return instructions. |
| Topic | How the Sources Differ | Guideline Position |
|---|---|---|
| Antibiotic duration | Baylor gives shorter consensus-based maximum durations for selected medical NEC; Belize uses older 7–10 or 10–14 day language. | Use shorter effective courses when clinically improving and source control is adequate; individualize for culture results, operative findings, and local antimicrobial stewardship. |
| Ultrasound | Baylor highlights bedside ultrasound when radiographs are equivocal; Belize also notes ultrasound can identify small free gas/fluid/ascites. | Use ultrasound as an adjunct, especially with gasless abdomen or equivocal radiographs, but do not let it delay surgical intervention for obvious perforation. |
| Surgery choice | Sources agree that drain and laparotomy both have roles; patient size, stability, anatomy, and surgeon judgment determine approach. | In unstable ELBW infants, primary peritoneal drainage may be a bridge or definitive therapy; stable/larger infants with necrotic bowel often need laparotomy. |
| Prevention | All sources support human milk and standardized feeding; probiotic guidance varies internationally. | Prioritize human milk, feeding protocols, perfusion, antibiotic stewardship, and local probiotic policy with attention to product quality and AAP cautions. |
“Your baby has signs that may mean the intestine is inflamed or, less commonly, has developed a small perforation. We are stopping feeds, decompressing the stomach, checking blood tests and X-rays, starting antibiotics when needed, and involving the surgical team early. Some babies improve with medical treatment, while others need a drain or surgery. We will update you frequently and support milk expression so feeding can restart safely when the bowel recovers.”